Janus Henderson Group PLC Grows Stake in ICU Medical, Inc. $ICUI

Janus Henderson Group PLC lifted its position in ICU Medical, Inc. (NASDAQ:ICUI) by 3.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,676,012 shares of the medical instruments supplier’s stock after buying an additional 99,256 shares during the period. Janus Henderson Group PLC owned approximately 0.11% of ICU Medical worth $345,607,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of ICUI. AQR Capital Management LLC lifted its holdings in ICU Medical by 2.5% in the first quarter. AQR Capital Management LLC now owns 9,360 shares of the medical instruments supplier’s stock valued at $1,297,000 after acquiring an additional 229 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in ICU Medical by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,764 shares of the medical instruments supplier’s stock worth $1,772,000 after purchasing an additional 560 shares during the last quarter. United Services Automobile Association bought a new stake in shares of ICU Medical during the 1st quarter valued at about $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of ICU Medical by 32.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 68,211 shares of the medical instruments supplier’s stock valued at $9,472,000 after purchasing an additional 16,680 shares during the period. Finally, Intech Investment Management LLC increased its position in shares of ICU Medical by 38.6% during the 1st quarter. Intech Investment Management LLC now owns 11,938 shares of the medical instruments supplier’s stock valued at $1,658,000 after purchasing an additional 3,326 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on ICUI. KeyCorp increased their price objective on shares of ICU Medical from $164.00 to $182.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. Needham & Company LLC upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $165.00 target price for the company in a research report on Wednesday, May 27th. Wall Street Zen raised shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Zacks Research downgraded shares of ICU Medical from a “strong-buy” rating to a “hold” rating in a research report on Tuesday. Finally, Jefferies Financial Group upgraded shares of ICU Medical to a “strong-buy” rating in a research note on Thursday, May 7th. Two investment analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, ICU Medical currently has an average rating of “Moderate Buy” and an average target price of $172.00.

Insider Activity at ICU Medical

In other ICU Medical news, VP Virginia Ruth Sanzone sold 2,447 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $124.08, for a total transaction of $303,623.76. Following the sale, the vice president owned 19,460 shares in the company, valued at approximately $2,414,596.80. This trade represents a 11.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director David C. Greenberg sold 2,424 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $122.91, for a total transaction of $297,933.84. Following the sale, the director owned 7,960 shares in the company, valued at approximately $978,363.60. The trade was a 23.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 2.10% of the company’s stock.

ICU Medical Stock Performance

Shares of ICUI opened at $168.38 on Friday. The company has a quick ratio of 1.17, a current ratio of 2.34 and a debt-to-equity ratio of 0.60. The business has a 50-day simple moving average of $147.31 and a two-hundred day simple moving average of $140.11. The stock has a market cap of $4.21 billion, a price-to-earnings ratio of 91.02, a PEG ratio of 2.33 and a beta of 0.76. ICU Medical, Inc. has a 52 week low of $107.00 and a 52 week high of $170.81.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $1.97 EPS for the quarter, topping the consensus estimate of $1.78 by $0.19. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The firm had revenue of $525.77 million for the quarter, compared to the consensus estimate of $520.65 million. During the same quarter last year, the company earned $1.72 earnings per share. The business’s revenue for the quarter was down 12.3% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. On average, analysts expect that ICU Medical, Inc. will post 6.51 EPS for the current year.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.